MedPath
HSA Approval

DAFLON TABLET 500 mg

SIN01067P

DAFLON TABLET 500 mg

DAFLON TABLET 500 mg

May 12, 1988

SERVIER (S) PTE LTD

SERVIER (S) PTE LTD

Regulatory Information

SERVIER (S) PTE LTD

SERVIER (S) PTE LTD

Therapeutic

General Sale List

Formulation Information

TABLET, SUGAR COATED

**Dosage and method of administration** _Usual dose in chronic conditions:_ 2 tablets daily in two divided doses morning and evening at mealtimes. _In acute hemorrhoidal attacks:_ 6 tablets daily (in 3 divided doses) for 3 to 4 days, then 4 tablets daily (in 2 divided doses)

ORAL

Medical Information

**Therapeutic indications** Treatment of organic and functional chronic venous insufficiency of the lower limbs with the following symptoms: - Swollen legs - Pain - Nocturnal cramps. Treatment of chronic hemorrhoids and acute hemorrhoidal attacks.

**Contraindications** Do not take Daflon® 500 if you are allergic (hypersensitive) to micronized purified flavonoid fraction or any of the other ingredients.

C05CA53

diosmin, combinations

Manufacturer Information

SERVIER (S) PTE LTD

LES LABORATOIRES SERVIER INDUSTRIE

Active Ingredients

DIOSMIN

450 mg

Diosmin

HESPERIDIN

50 mg

Hesperidin

Documents

Patient Information Leaflets

Daflon_PIL.pdf

Approved: April 18, 2023

Download
© Copyright 2025. All Rights Reserved by MedPath